Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Patriarca

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Haematologica|November 9, 2004
Infliximab treatment for steroid-refractory acute graft-versus-host diseaseFrancesca Patriarca, Alessandra Sperotto, Daniela Damiani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.
Frontiers in Oncology|February 9, 2023
Experts' consensus on the definition and management of high risk multiple myelomaChiara Marcon, Valentina Simeon, Paola Deias, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2015
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)Cristina Nanni, Elena Zamagni, Annibale Versari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availabilityFrancesca Patriarca, Hermann Einsele, Francesco Spina, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2015
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantationFrancesca Patriarca, Francesca Carobolante, Elena Zamagni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)Cristina Nanni, Annibale Versari, Stephane Chauvie, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Haematologica|November 9, 2004
Infliximab treatment for steroid-refractory acute graft-versus-host diseaseFrancesca Patriarca, Alessandra Sperotto, Daniela Damiani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.
Frontiers in Oncology|February 9, 2023
Experts' consensus on the definition and management of high risk multiple myelomaChiara Marcon, Valentina Simeon, Paola Deias, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2015
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)Cristina Nanni, Elena Zamagni, Annibale Versari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availabilityFrancesca Patriarca, Hermann Einsele, Francesco Spina, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2015
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantationFrancesca Patriarca, Francesca Carobolante, Elena Zamagni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)Cristina Nanni, Annibale Versari, Stephane Chauvie, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Pageof 16